For patients who are living with a complex disease, there can be many barriers for medication access – including economic, psycho-social, logistics, culture and education. For the pharmaceutical industry, understanding how to address these barriers is the first step toward ensuring that every patient has the chance to receive the full benefit of therapy.
One important way that many companies help patients remove access barriers is by establishing patient assistance programs (PAPs). PAPs play a critical role in facilitating access to therapy for uninsured and underinsured patients, as well as those experiencing delays in access due to a lengthy prior authorization process. PAPs also support continuity of care for patients who may have a gap in coverage due a job change or other life events.
For pharma leaders considering a PAP, follow these steps to provide optimal support to patients: